Subscribe
Logo small
Search
banner

AOTMiT: Transparency Council on Parkinson's disease, epilepsy and primary hypercholesterolemia, among others

MedExpress Team

medexpress.pl

Published March 4, 2024 08:50

AOTMiT: Transparency Council on Parkinson's disease, epilepsy and primary hypercholesterolemia, among others - Header image
Źródło: AOTMiT
Today (March 4) another meeting of the Transparency Council.

The agenda includes:

  1. Preparation of a position paper on the evaluation of the drug Ngenla (somatrogonum) within the framework of the drug program B.19. "Treatment of low-grade children with somatotropin hypopituitarism (ICD-10: E23)".
  2. Preparation of a position paper on the evaluation of the drug Produodopa (foslevodopum + foscarbidopum) under the drug program B.90. "Treatment of ...

    Content locked

    To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].

    If you already have an account, please log in

Szukaj nowych pracowników

Dodaj ogłoszenie już za 4 zł dziennie*.

* 4 zł netto dziennie. Minimalny okres ekspozycji ogłoszenia to 30 dni.

Read also